These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8724448)

  • 41. Scopolamine reversal of tremor produced by low doses of physostigmine in rats: evidence for a cholinergic mechanism.
    Stanford JA; Fowler SC
    Neurosci Lett; 1997 Apr; 225(3):157-60. PubMed ID: 9147394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scopolamine model of dementia: electroencephalogram findings and cognitive performance.
    Ebert U; Kirch W
    Eur J Clin Invest; 1998 Nov; 28(11):944-9. PubMed ID: 9824440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey.
    Antal A; Kovanecz I; Bodis-Wollner I
    Physiol Behav; 1994 Jul; 56(1):161-6. PubMed ID: 8084895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
    Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M
    Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice.
    Steckler T; Holsboer F
    Brain Res; 2001 Jul; 906(1-2):46-59. PubMed ID: 11430861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.
    Parrott AC; Wesnes K
    Psychopharmacology (Berl); 1987; 92(4):513-9. PubMed ID: 3114803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
    Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
    Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
    Araujo JA; Studzinski CM; Milgram NW
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restricted sedation and absence of cognitive impairments after administration of intranasal scopolamine.
    Weerts AP; Pattyn N; Putcha L; Hoag SW; Van Ombergen A; Hallgren E; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2015 Dec; 29(12):1231-5. PubMed ID: 26268532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans.
    Brass EP; Polinsky R; Sramek JJ; Moore M; Jones D; Veroff AE; Wardle TS; Cutler NR
    J Clin Psychopharmacol; 1995 Feb; 15(1):58-62. PubMed ID: 7714229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-related cholinergic drug effects on analgesia in two inbred strains of mice.
    Fagioli S; Consorti D; Pavone F
    Brain Res; 1990 Feb; 510(1):150-3. PubMed ID: 2322840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine.
    Bartus RT; Johnson HR
    Pharmacol Biochem Behav; 1976 Jul; 5(1):39-46. PubMed ID: 825880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging.
    Savonenko AV; Markowska AL
    Neuroscience; 2003; 119(3):821-30. PubMed ID: 12809703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential metformin dose-dependent effects on cognition in rats: role of Akt.
    Mostafa DK; Ismail CA; Ghareeb DA
    Psychopharmacology (Berl); 2016 Jul; 233(13):2513-24. PubMed ID: 27113224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of dimenhydrinate, cinnarizine and transdermal scopolamine on performance.
    Gordon CR; Gonen A; Nachum Z; Doweck I; Spitzer O; Shupak A
    J Psychopharmacol; 2001 Sep; 15(3):167-72. PubMed ID: 11565623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Verbal fluency facilitated by the cholinergic blocker, scopolamine.
    Pompéia S; Rusted JM; Curran HV
    Hum Psychopharmacol; 2002 Jan; 17(1):51-9. PubMed ID: 12404707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of scopolamine and nicotine on human rapid information processing performance.
    Wesnes K; Warburton DM
    Psychopharmacology (Berl); 1984; 82(3):147-50. PubMed ID: 6425892
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.